Startup Vima Adds Parkinson’s to Movement Disorder Scope, Expanding Series A Round to $100M – MedCity News
When Vima Therapeutics launched last year to take its drug candidate into human testing, the lead indication was isolated dystonia,…
When Vima Therapeutics launched last year to take its drug candidate into human testing, the lead indication was isolated dystonia,…
On Thursday, OpenAI announced its investment in neurotech startup Merge Labs, cofounded by its CEO, billionaire Sam Altman. OpenAI will…
While there’s growing evidence that psychedelic drugs can effectively treat severe mental health conditions, especially in cases where traditional treatments…